Ob.Gyn. NewsOsteoporosis, osteoarthritis risk high among cerebral palsy patientsJuly 11, 2019Osteoporosis
Ob.Gyn. NewsOnce-weekly teriparatide still achieves bone mineral density gainsJuly 11, 2019Osteoporosis
Ob.Gyn. NewsOsteoporotic fracture risk appears higher in adults with hemophiliaJuly 11, 2019Osteoporosis
Ob.Gyn. NewsBisphosphonates before denosumab may prevent postdenosumab BMD rebound effectJune 20, 2019OsteoporosisPreventive Care
Ob.Gyn. NewsConsider drug treatment in late-life women with osteoporosisJune 17, 2019OsteoporosisPreventive Care
OBG ManagementAn app to help women and clinicians manage menopausal symptomsJune 4, 2019MenopauseOsteoporosis
Ob.Gyn. NewsEmerging data support anabolic-first regimens for severe osteoporosisMay 14, 2019OsteoporosisPreventive Care
Ob.Gyn. NewsKnowledge gaps about long-term osteoporosis drug therapy benefits, risks remain largeMay 1, 2019Preventive CareOsteoporosis
Ob.Gyn. NewsRomosozumab gets FDA approval for treating osteoporosisApril 9, 2019OsteoporosisMenopause
Ob.Gyn. NewsNew postmenopausal osteoporosis guidelines emphasize patient prioritiesMarch 27, 2019OsteoporosisGynecology
Ob.Gyn. NewsFDA committee votes yes on romosozumab for osteoporosisJanuary 16, 2019OsteoporosisPreventive Care
Ob.Gyn. NewsSpending on medical marketing increased by $12.2 billion over the last 2 decadesJanuary 8, 2019Practice ManagementBusiness of MedicineOsteoporosis
